Spruce Biosciences, Inc.

SPRB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 13, 2026 8-K
SCHEDULE 13G/A May 7, 2026
SCHEDULE 13G Apr 28, 2026
8-K Apr 22, 2026 8-K
424B5 Apr 21, 2026 424B5
424B5 Apr 20, 2026 424B5
ARS Apr 9, 2026 ARS
DEFA14A Apr 9, 2026 DEFA14A
DEF 14A Apr 9, 2026 DEF 14A
8-K Mar 20, 2026 8-K
4 Mar 9, 2026
3 Mar 9, 2026
424B5 Mar 9, 2026 424B5
S-8 Mar 9, 2026 S-8
8-K Mar 9, 2026 8-K
10-K Mar 9, 2026 10-K
SCHEDULE 13G Feb 24, 2026
SCHEDULE 13D/A Feb 18, 2026
SCHEDULE 13G Feb 17, 2026
SCHEDULE 13G Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G Feb 10, 2026
8-K Feb 5, 2026 8-K
4 Jan 21, 2026
← Newer Page 2 of 15 · 366 filings Older →